18 November 2021

Why the first penguin of pay for delay has not come in Japan-Anatomy of the Japanese Paradox

In this session Takanori Abe will explore the reasons why reverse payment cases are so scant in Japan.  With their low invalidation rate of substance patents, and the stable supply obligation after the launch of generic drugs, the system in Japan makes reverse payments very difficult.  On the other hand, the reasons why actual reverse payments cases have not arisen in Japan cannot be solely explained by the systems in place.  The attitude of Japanese companies’ towards regulatory authorities may be a significant factor.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk